Abstract
Background: Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for medication-refractory major depression, yet the mechanisms of action for this intervention are poorly understood. Here we investigate cerebral cortex thickness as a possible biomarker of rTMS treatment response. Methods: Longitudinal change in cortical thickness is evaluated relative to clinical outcomes across 48 participants in 2 cohorts undergoing left dorsolateral prefrontal cortex rTMS as a treatment for depression. Results: Our results reveal changes in thickness in a region of the left rostral anterior cingulate cortex that correlate with clinical response, with this region becoming thicker in patients who respond favorably to rTMS and thinner in patients with a less favorable response. Moreover, the baseline cortical thickness in this region correlates with rTMS treatment response – those patients with thinner cortex before treatment tended to have the most clinical improvement. Conclusions: This study is the first analysis of longitudinal cortical thickness change with rTMS as a treatment for depression with similar results across two cohorts. These results support further investigation into the use of structural MRI as a possible biomarker of rTMS treatment response.
Author supplied keywords
Cite
CITATION STYLE
Boes, A. D., Uitermarkt, B. D., Albazron, F. M., Lan, M. J., Liston, C., Pascual-Leone, A., … Fox, M. D. (2018). Rostral anterior cingulate cortex is a structural correlate of repetitive TMS treatment response in depression. Brain Stimulation, 11(3), 575–581. https://doi.org/10.1016/j.brs.2018.01.029
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.